Piperazine

Piperazine

SCHEMBL27623601

C1CNCCN1.CCC(C)=O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
TDP1 Q9NUW8 2/20 0.62
HIF1A Q16665 1/20 0.38
MAPT P10636 1/20 0.38
PDE4A P27815 1/20 0.38
KDR P35968 1/20 0.38
FFAR3 O14843 1/20 0.37
TRPA1 O75762 1/20 0.35
CHRNB2 P17787 3/20 0.33
CHRNA3 P32297 3/20 0.33
CHRNA4 P43681 3/20 0.33
CHRNB4 P30926 2/20 0.33
CHRNA7 P36544 2/20 0.33
CHRNB3 Q05901 1/20 0.32
CHRNA6 Q15825 1/20 0.32
GABRP O00591 1/20 0.32
GABRD O14764 1/20 0.32
GABRA1 P14867 1/20 0.32
TSHR P16473 1/20 0.32
GABRB1 P18505 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL28229779 0.97 ALDH1A1 (0.59) ALDH1A1TDP1HIF1AMAPTPDE4A
Piperazine SCHEMBL28047208 0.82 FFAR3 (0.56) ALDH1A1TDP1HIF1AMAPTPDE4A
Piperazine SCHEMBL27871604 0.81 TDP1 (0.62) ALDH1A1TDP1HIF1AMAPTPDE4A
Piperazine SCHEMBL5818604 0.81 FFAR3 (0.62) ALDH1A1TDP1HIF1AMAPTPDE4A
Piperazine SCHEMBL28214068 0.81 FFAR3 (0.62) ALDH1A1TDP1HIF1AMAPTPDE4A
Piperazine SCHEMBL2429468 0.79 LMNA (0.50) HIF1AMAPTPDE4AKDRFFAR3
Butanone SCHEMBL1510153 0.79
Butanone SCHEMBL1039820 0.79 ALDH1A1 (1.00) ALDH1A1TDP1FFAR3TRPA1TSHR
Butanone SCHEMBL8379087 0.79 ALDH1A1 (1.00) ALDH1A1TDP1FFAR3TRPA1TSHR
Butanone SCHEMBL27495689 0.79 ALDH1A1 (1.00) ALDH1A1TDP1FFAR3TRPA1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1780611-B Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer PURDUE PHARMA LTD 2013-01-30 CN disclosed
CN-1780611-A Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer PURDUE PHARMA LTD (US) 2006-05-31 CN disclosed